Literature DB >> 29967894

Neurological Critical Care Services' Influence Following Large Hemispheric Infarction and Their Impact on Resource Utilization.

Syed Omar Shah1,2,3,4, Yu Kan Au1, Fred Rincon1,2,3,4, Matthew Vibbert1,2,3,4.   

Abstract

INTRODUCTION: Acute ischemic stroke (AIS) is the fourth leading cause of death in the US. Numerous studies have demonstrated the use of comprehensive stroke units and neurological intensive care units (NICU) in improving outcomes after stroke. We hypothesized that an expanded neurocritical care (NCC) service would decrease resource utilization in patients with LHI.
METHODS: Retrospective data from consecutive admissions of large hemispheric infarction (LHI) patients requiring mechanical ventilation were acquired from the hospital medical records. Between 2011-2013, there were 187 consecutive patients admitted to the Jefferson Hospital for Neuroscience (Philadelphia, USA) with AIS and acute respiratory failure. Our intention was to determine the number of tracheostomies done over time. The primary outcome measure was the number of tracheostomies over time. Secondary outcomes were, ventilator-free days (Vfd), total hospital charges, intensive care unit length of stay (ICU-LOS), and total hospital length of stay (hospital-LOS), including ICU LOS. Hospital charges were log-transformed to meet assumptions of normality and homoscedasticity of residual variance terms. Generalized Linear Models were used and ORs and 95% CIs calculated. The significance level was set at α = 0.05.
RESULTS: Of the 73 patients included in this analysis, 33% required a tracheostomy. There was a decrease in the number of tracheostomies undertaken since 2011. (OR 0.8; 95% CI 0.6-0.9: p=0.02).Lower Vfd were seen in tracheostomized patients (OR 0.11; 95%CI 0.1-0.26: p<0.0001). The log-hospital charges decreased over time but not significantly (OR 0.9; 95%CI 0.78-1.07: p=0.2) and (OR 0.99; 95%CI 0.85-1.16: p=0.8) from 2012 to 2013 respectively.The ICU-LOS at 23 days vs 10 days (p=0.01) and hospital-LOS at 33 days vs 11 days (p=0.008) were higher in tracheostomized patients.
CONCLUSION: The data suggest that in LHI-patients requiring mechanical ventilation, a dedicated NCC service reduces the overall need for tracheostomy, increases Vfd, and decreases ICU and hospital-LOS.

Entities:  

Keywords:  extubation; large hemispheric infarct; malignant stroke; neurocritical care; neurological critical care; resource utilization; tracheostomy

Year:  2018        PMID: 29967894      PMCID: PMC5953264          DOI: 10.1515/jccm-2018-0001

Source DB:  PubMed          Journal:  J Crit Care Med (Targu Mures)        ISSN: 2393-1817


  22 in total

1.  Neurologic examination and extubation outcome in the neurocritical care unit.

Authors:  Christopher D Anderson; James F Bartscher; Patricia D Scripko; Alessandro Biffi; Deborah Chase; Mary Guanci; David M Greer
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

2.  Tracheostomy in a neuro-intensive care setting: indications and timing.

Authors:  W Y Koh; T W Lew; N M Chin; M F Wong
Journal:  Anaesth Intensive Care       Date:  1997-08       Impact factor: 1.669

3.  Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.

Authors:  Michel T Torbey; Julian Bösel; Denise H Rhoney; Fred Rincon; Dimitre Staykov; Arun P Amar; Panayiotis N Varelas; Eric Jüttler; DaiWai Olson; Hagen B Huttner; Klaus Zweckberger; Kevin N Sheth; Christian Dohmen; Ansgar M Brambrink; Stephan A Mayer; Osama O Zaidat; Werner Hacke; Stefan Schwab
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

4.  Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage.

Authors:  M N Diringer; D F Edwards
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Impact of a neurointensivist on outcomes in critically ill stroke patients.

Authors:  Lisa Knopf; Ilene Staff; Joao Gomes; Louise McCullough
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  Impact of a neurointensivist on outcomes in patients with head trauma treated in a neurosciences intensive care unit.

Authors:  Panayiotis N Varelas; Dan Eastwood; Hyun J Yun; Marianna V Spanaki; Lotfi Hacein Bey; Christos Kessaris; Thomas A Gennarelli
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

7.  Conventional weaning parameters do not predict extubation failure in neurocritical care patients.

Authors:  Richard Ko; Leah Ramos; Julio A Chalela
Journal:  Neurocrit Care       Date:  2009-01-28       Impact factor: 3.210

8.  Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.

Authors:  Timothy D Girard; John P Kress; Barry D Fuchs; Jason W W Thomason; William D Schweickert; Brenda T Pun; Darren B Taichman; Jan G Dunn; Anne S Pohlman; Paul A Kinniry; James C Jackson; Angelo E Canonico; Richard W Light; Ayumi K Shintani; Jennifer L Thompson; Sharon M Gordon; Jesse B Hall; Robert S Dittus; Gordon R Bernard; E Wesley Ely
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

9.  Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients.

Authors:  Eric M Bershad; Eliahu S Feen; Olga H Hernandez; M Fareed K Suri; Jose I Suarez
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  Early tracheostomy in ventilated stroke patients: Study protocol of the international multicentre randomized trial SETPOINT2 (Stroke-related Early Tracheostomy vs. Prolonged Orotracheal Intubation in Neurocritical care Trial 2).

Authors:  Silvia Schönenberger; Wolf-Dirk Niesen; Hannah Fuhrer; Colleen Bauza; Christina Klose; Meinhard Kieser; José I Suarez; David B Seder; Julian Bösel
Journal:  Int J Stroke       Date:  2016-01-05       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.